Economics of medically unexplained symptoms: A systematic review of the literature

Psychotherapy and Psychosomatics

Volumn 81, Issue 5, 2012, Pages 265-275

  Konnopka, Alexander ^a   Schaefert, Rainer ^b   Heinrich, Sven ^a   Kaufmann, Claudia ^b   Luppa, Melanie ^c   Herzog, Wolfgang ^b   Knig, Hans Helmut ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Cost of illness; Cost effectiveness; Economic evaluations; Medically unexplained symptoms; Somatization disorder

Indexed keywords

COGNITIVE THERAPY; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH ECONOMICS; HOSPITALIZATION; HUMAN; PATIENT EDUCATION; PHYSICIAN; PRIORITY JOURNAL; REVIEW; SOMATIZATION; SYMPTOM; UNITED STATES;

COST OF ILLNESS; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HEALTH SERVICES; HUMANS; RESEARCH DESIGN; SOMATOFORM DISORDERS;

EID: 84864110278     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000337349     Document Type: Review

References (33)

1. Fink P, Sorensen L, Engberg M, Holm M, Munk-Jorgensen P: Somatization in primary care. Prevalence, health care utilization, and general practitioner recognition. Psychosomatics 1999; 40: 330-338.
2. de Waal MW, Arnold IA, Eekhof JA, van Hemert AM: Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders. Br J Psychiatry 2004; 184: 470-476.
3. Toft T, Fink P, Oernboel E, Christensen K, Frostholm L, Olesen F: Mental disorders in primary care: prevalence and co-morbidity among disorders. Results from the functional illness in primary care (FIP) study. Psychol Med 2005; 35: 1175-1184.
4. Huijbregts KM, van Marwijk HW, de Jong FJ, Schreuders B, Beekman AT, van der Feltz-Cornelis CM: Adverse effects of multiple physical symptoms on the course of depressive and anxiety symptoms in primary care. Psychother Psychosom 2010; 79: 389-391.
5. Smith GR Jr: The course of somatization and its effects on utilization of health care resources. Psychosomatics 1994; 35: 263-267.
6. Hiller W, Fichter MM: High utilizers of medical care: a crucial subgroup among somatizing patients. J Psychosom Res 2004; 56: 437-443.
7. Smith GR Jr, Monson RA, Ray DC: Psychiatric consultation in somatization disorder. A randomized controlled study. N Engl J Med 1986; 314: 1407-1413.
8. Kashner TM, Rost K, Smith GR, Lewis S: An analysis of panel data. The impact of a psychiatric consultation letter on the expenditures and outcomes of care for patients with somatization disorder. Med Care 1992; 30: 811-821.
9. Briggs AH, O'Brien BJ: The death of costminimization analysis? Health Econ 2001; 10: 179-184.
10. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL: Methods for the Economic Evaluation of Health Care Programmes, ed 3. Oxford, Oxford University Press, 2005.
11. Annemans L, Le Lay K, Taieb C: Societal and patient burden of fibromyalgia syndrome. Pharmacoeconomics 2009; 27: 547-559.
12. Agarwal N, Spiegel BM: The effect of irritable bowel syndrome on health-related quality of life and health care expenditures. Gastroenterol Clin North Am 2011; 40: 11-19.
13. Organisation for Economic Cooperation and Development: OECD Health Data 2009: Statistics and Indicators for 30 Countries. 2009.
14. Smith GR Jr, Monson RA, Ray DC: Patients with multiple unexplained symptoms. Their characteristics, functional health, and health care utilization. Arch Intern Med 1986; 146: 69-72.
15. Smith GR Jr, Rost K, Kashner TM: A trial of the effect of a standardized psychiatric consultation on health outcomes and costs in somatizing patients. Arch Gen Psychiatry 1995; 52: 238-243.
16. Labott SM, Preisman RC, Popovich J Jr, Iannuzzi MC: Health care utilization of somatizing patients in a pulmonary subspecialty clinic. Psychosomatics 1995; 36: 122-128.
17. Barsky AJ, Ettner SL, Horsky J, Bates DW: Resource utilization of patients with hypochondriacal health anxiety and somatization. Med Care 2001; 39: 705-715.
18. Barsky AJ, Orav EJ, Bates DW: Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry 2005; 62: 903-910.
19. McFall M, Tackett J, Maciejewski ML, Richardson RD, Hunt SC, Roberts L: Predicting costs of Veterans Affairs health care in Gulf War veterans with medically unexplained physical symptoms. Mil Med 2005; 170: 70-75.
20. Luo Z, Goddeeris J, Gardiner JC, Smith RC: Costs of an intervention for primary care patients with medically unexplained symptoms: a randomized controlled trial. Psychiatr Serv 2007; 58: 1079-1086.
21. Seivewright H, Green J, Salkovskis P, Barrett B, Nur U, Tyrer P: Cognitive-behavioural therapy for health anxiety in a genitourinary medicine clinic: randomised controlled trial. Br J Psychiatry 2008; 193: 332-337.
22. Hiller W, Fichter MM, Rief W: A controlled treatment study of somatoform disorders including analysis of healthcare utilization and cost-effectiveness. J Psychosom Res 2003; 54: 369-380.
23. Morriss R, Gask L, Ronalds C, Downes-Grainger E, Thompson H, Leese B, Goldberg D: Cost-effectiveness of a new treatment for somatized mental disorder taught to GPs. Fam Pract 1998; 15: 119-125.
24. Allen LA, Woolfolk RL, Escobar JI, Gara MA, Hamer RM: Cognitive-behavioral therapy for somatization disorder: a randomized controlled trial. Arch Intern Med 2006; 166: 1512-1518.
25. Efron B, Tibshirani R: Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci 1986; 1: 54-77.
26. Luppa M, Heinrich S, Angermeyer MC, König HH, Riedel-Heller SG: Cost-of-illness studies of depression: a systematic review. J Affect Disord 2007; 98: 29-43.
27. Konnopka A, Leichsenring F, Leibing E, König HH: Cost-of-illness studies and costeffectiveness analyzes in anxiety disorders: a systematic review. J Affect Disord 2009; 114: 14-31.
28. Fink P, Rosendal M: Recent developments in the understanding and management of functional somatic symptoms in primary care. Curr Opin Psychiatry 2008; 21: 182-188.
29. Toft T, Rosendal M, Ornbol E, Olesen F, Frostholm L, Fink P: Training general practitioners in the treatment of functional somatic symptoms: effects on patient health in a cluster-randomised controlled trial (the Functional Illness in Primary Care study). Psychother Psychosom 2010; 79: 227-237.
30. van Bokhoven MA, Koch H, van der Weijden T, Grol RP, Kester AD, Rinkens PE, Bindels PJ, Dinant GJ: Influence of watchful waiting on satisfaction and anxiety among patients seeking care for unexplained complaints. Ann Fam Med 2009; 7: 112-120.
31. Henningsen P, Zipfel S, Herzog W: Management of functional somatic syndromes. Lancet 2007; 369: 946-955.
32. van der Feltz-Cornelis CM, van Oppen P, Ader HJ, van Dyck R: Randomised controlled trial of a collaborative care model with psychiatric consultation for persistent medically unexplained symptoms in general practice. Psychother Psychosom 2006; 75: 282-289.
33. Fava GA, Sonino N: Psychosomatic medicine: a name to keep. Psychother Psychosom 2010; 79: 1-3.